Increased levels have been found in the plasma of patients hospitalised with COVID-19 [227], while auto-antibodies against the endothelin-1 type A receptor (ETAR) have been found to be significantly increased in COVID-19 patients with an unfavourable disease course [228]. The gene discussed is EDNRA; the disease is COVID-19.